Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,039 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rituximab Resistance in Glomerular Diseases: A GlomCon Mini Review.
Salehi T, Krishnan A, Al Jurdi A, So P, Lerma E, Wiegley N; GlomCon Editorial Team. Salehi T, et al. Among authors: krishnan a. Kidney Med. 2024 Feb 16;6(4):100791. doi: 10.1016/j.xkme.2024.100791. eCollection 2024 Apr. Kidney Med. 2024. PMID: 38495600 Free PMC article.
Approach to Pregnancy in Patients With Lupus Nephritis.
Tan B, So PN, Krishnan A, Carriazo S, Bahamonde JR, Lamech TM, Hassanein M, Lerma E, Wiegley N; GlomCon Editorial Team. Tan B, et al. Among authors: krishnan a. Kidney Med. 2023 Sep 17;5(11):100724. doi: 10.1016/j.xkme.2023.100724. eCollection 2023 Nov. Kidney Med. 2023. PMID: 37915962 Free PMC article.
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
The incidence of cancer recurrence and new cancer following commencement of dialysis.
Lim WH, Ooi E, Pankaj A, Teixeira-Pinto A, Lin Y, Johnson DW, Hawley CM, Viecelli AK, Pilmore H, Roberts MA, Davies CE, Krishnan A, Wong G. Lim WH, et al. Among authors: krishnan a. Clin Kidney J. 2022 Jun 2;15(9):1770-1781. doi: 10.1093/ckj/sfac124. eCollection 2022 Sep. Clin Kidney J. 2022. PMID: 36003660 Free PMC article.
Health-Related Quality of Life in People Across the Spectrum of CKD.
Krishnan A, Teixeira-Pinto A, Lim WH, Howard K, Chapman JR, Castells A, Roger SD, Bourke MJ, Macaskill P, Williams G, Lok CE, Diekmann F, Cross N, Sen S, Allen RDM, Chadban SJ, Pollock CA, Turner R, Tong A, Yang JYH, Williams N, Au E, Kieu A, James L, Francis A, Wong G, Craig JC. Krishnan A, et al. Kidney Int Rep. 2020 Oct 3;5(12):2264-2274. doi: 10.1016/j.ekir.2020.09.028. eCollection 2020 Dec. Kidney Int Rep. 2020. PMID: 33305120 Free PMC article.
2,039 results